Cullinan Therapeutics Inc
CGEMHealthcare|Biotechnology|USA
$18.13
-0.24 (-1.31%)
Tangible Book
$5.96
Earnings Power
$7.63
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (129)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Michaelson Jennifer | Chief Scientific Officer | 2026-07-06 | SELL | 8,000 | $17.82 | $142.6K |
| Michaelson Jennifer | Chief Scientific Officer | 2026-05-05 | SELL | 8,000 | $14.62 | $117K |
| Michaelson Jennifer | Chief Scientific Officer | 2026-03-05 | SELL | 8,000 | $15.68 | $125.4K |
| Michaelson Jennifer | Chief Scientific Officer | 2026-02-25 | SELL | 1,780 | $14.14 | $25.2K |
| Jones Jeffrey Alan | Chief Medical Officer | 2026-02-24 | SELL | 4,582 | $14.47 | $66.3K |
| SUMER JACQUELYN L | Chief Legal Officer | 2026-02-24 | SELL | 3,601 | $14.47 | $52.1K |
| Michaelson Jennifer | Chief Scientific Officer | 2026-02-24 | SELL | 5,353 | $14.31 | $76.6K |
| AHMED NADIM | President and CEO | 2026-02-24 | SELL | 13,515 | $14.47 | $195.6K |
| Jones Jeffrey Alan | Chief Medical Officer | 2026-02-20 | SELL | 4,982 | $13.62 | $67.9K |
| Michaelson Jennifer | Chief Scientific Officer | 2026-02-20 | SELL | 11,742 | $14.08 | $165.3K |
| SUMER JACQUELYN L | Chief Legal Officer | 2026-02-20 | SELL | 3,742 | $13.62 | $51K |
| AHMED NADIM | President and CEO | 2026-02-20 | SELL | 16,381 | $13.62 | $223.1K |
| Fenton Mary Kay | CFO | 2026-02-20 | SELL | 4,398 | $13.62 | $59.9K |
| Michaelson Jennifer | Chief Scientific Officer | 2026-02-12 | SELL | 416 | $12.03 | $5K |
| Michaelson Jennifer | Chief Scientific Officer | 2026-01-22 | SELL | 4,000 | $12.3 | $49.2K |
| AHMED NADIM | President and CEO | 2025-12-23 | SELL | 9,922 | $10.01 | $99.3K |
| Michaelson Jennifer | Chief Scientific Officer | 2025-12-19 | SELL | 1,345 | $10.01 | $13.5K |
| SUMER JACQUELYN L | Chief Legal Officer | 2025-12-18 | SELL | 3,480 | $9.67 | $33.7K |
| Jones Jeffrey Alan | Chief Medical Officer | 2025-12-18 | SELL | 4,632 | $9.67 | $44.8K |
| Michaelson Jennifer | Chief Scientific Officer | 2025-12-18 | SELL | 2,898 | $9.67 | $28K |
| Michaelson Jennifer | Chief Scientific Officer | 2025-12-15 | SELL | 3,143 | $12.23 | $38.4K |
| Lynx1 Capital Management LP | 10% Owner | 2025-10-28 | BUY | 165,667 | $8.4 | $1391.6K |
| Lynx1 Capital Management LP | 10% Owner | 2025-10-17 | BUY | 248,749 | $8.46 | $2104.4K |
| Lynx1 Capital Management LP | 10% Owner | 2025-10-10 | BUY | 1,459,641 | $6.73 | $9823.4K |
| Jones Jeffrey Alan | Chief Medical Officer | 2025-02-25 | SELL | 4,895 | $8.53 | $41.8K |
| AHMED NADIM | President and CEO | 2025-02-25 | SELL | 12,529 | $8.53 | $106.9K |
| Michaelson Jennifer | Chief Scientific Officer | 2025-02-25 | SELL | 3,756 | $8.53 | $32K |
| SUMER JACQUELYN L | Chief Legal Officer | 2025-02-25 | SELL | 3,756 | $8.53 | $32K |
| Michaelson Jennifer | Chief Scientific Officer | 2025-01-06 | SELL | 4,000 | $12.51 | $50K |
| AHMED NADIM | President and CEO | 2024-12-24 | SELL | 8,400 | $11.87 | $99.7K |
| Michaelson Jennifer | Chief Scientific Officer | 2024-12-18 | SELL | 4,693 | $11.41 | $53.5K |
| Jones Jeffrey Alan | Chief Medical Officer | 2024-12-18 | SELL | 4,632 | $11.41 | $52.9K |
| SUMER JACQUELYN L | Chief Legal Officer | 2024-12-18 | SELL | 3,482 | $11.41 | $39.7K |
| Michaelson Jennifer | Chief Scientific Officer | 2024-12-12 | SELL | 3,489 | $12.52 | $43.7K |
| Michaelson Jennifer | Chief Scientific Officer | 2024-11-05 | SELL | 8,000 | $15.64 | $125.1K |
| Michaelson Jennifer | Chief Scientific Officer | 2024-09-05 | SELL | 8,000 | $18.09 | $144.7K |
| Michaelson Jennifer | Chief Scientific Officer | 2024-07-05 | SELL | 8,000 | $16.33 | $130.6K |
| Michaelson Jennifer | Chief Scientific Officer | 2024-05-07 | SELL | 63,606 | $28.25 | $1796.9K |
| Savill Corrine | Chief Business Officer | 2024-02-01 | SELL | 40,000 | $16.18 | $647.2K |
| Savill Corrine | Chief Business Officer | 2024-01-29 | SELL | 40,000 | $14.09 | $563.6K |
| Savill Corrine | Chief Business Officer | 2024-01-23 | SELL | 40,000 | $12.31 | $492.4K |
| AHMED NADIM | President and CEO | 2023-12-26 | SELL | 4,272 | $9.24 | $39.5K |
| Jones Jeffrey Alan | Chief Medical Officer | 2023-12-21 | SELL | 1,860 | $8.5 | $15.8K |
| SUMER JACQUELYN L | Chief Legal Officer | 2023-12-21 | SELL | 1,400 | $8.5 | $11.9K |
| Trigilio Jeffrey | CFO | 2023-12-21 | SELL | 1,920 | $8.5 | $16.3K |
| Michaelson Jennifer | Chief Scientific Officer | 2023-12-21 | SELL | 1,145 | $8.5 | $9.7K |
| Jones Jeffrey Alan | Chief Medical Officer | 2023-12-18 | SELL | 386 | $8.22 | $3.2K |
| Michaelson Jennifer | Chief Scientific Officer | 2023-12-18 | SELL | 238 | $8.22 | $2K |
| SUMER JACQUELYN L | Chief Legal Officer | 2023-12-18 | SELL | 290 | $8.22 | $2.4K |
| Trigilio Jeffrey | CFO | 2023-12-18 | SELL | 398 | $8.22 | $3.3K |
| Trigilio Jeffrey | CFO | 2023-12-12 | SELL | 1,926 | $7.81 | $15K |
| Michaelson Jennifer | Chief Scientific Officer | 2023-12-12 | SELL | 1,068 | $7.81 | $8.3K |
| AHMED NADIM | President and CEO | 2023-06-28 | SELL | 759 | $11.4 | $8.7K |
| Jones Jeffrey Alan | Chief Medical Officer | 2023-06-20 | SELL | 387 | $12.94 | $5K |
| Michaelson Jennifer | Chief Development Officer | 2023-06-20 | SELL | 238 | $12.94 | $3.1K |
| Trigilio Jeffrey | CFO | 2023-06-20 | SELL | 399 | $12.94 | $5.2K |
| SUMER JACQUELYN L | Chief Legal Officer | 2023-06-20 | SELL | 291 | $12.94 | $3.8K |
| Trigilio Jeffrey | CFO | 2023-06-12 | SELL | 319 | $13.11 | $4.2K |
| Michaelson Jennifer | Chief Development Officer | 2023-06-12 | SELL | 176 | $13.11 | $2.3K |
| Michaelson Jennifer | Chief Development Officer | 2023-06-07 | SELL | 12,000 | $12.31 | $147.7K |
| AHMED NADIM | President and CEO | 2023-05-23 | SELL | 707 | $9.15 | $6.5K |
| SUMER JACQUELYN L | Chief Legal Officer | 2023-05-18 | SELL | 291 | $8.76 | $2.5K |
| Trigilio Jeffrey | CFO | 2023-05-18 | SELL | 399 | $8.76 | $3.5K |
| Jones Jeffrey Alan | Chief Medical Officer | 2023-05-18 | SELL | 394 | $8.76 | $3.5K |
| Michaelson Jennifer | Chief Development Officer | 2023-05-18 | SELL | 239 | $8.76 | $2.1K |
| Michaelson Jennifer | Chief Development Officer | 2023-05-12 | SELL | 193 | $8.78 | $1.7K |
| Trigilio Jeffrey | CFO | 2023-05-12 | SELL | 347 | $8.78 | $3K |
| AHMED NADIM | President and CEO | 2023-04-25 | SELL | 716 | $10.59 | $7.6K |
| Jones Jeffrey Alan | Chief Medical Officer | 2023-04-18 | SELL | 392 | $10.71 | $4.2K |
| Trigilio Jeffrey | CFO | 2023-04-18 | SELL | 398 | $10.71 | $4.3K |
| Michaelson Jennifer | Chief Development Officer | 2023-04-18 | SELL | 238 | $10.71 | $2.5K |
| SUMER JACQUELYN L | Chief Legal Officer | 2023-04-18 | SELL | 290 | $10.71 | $3.1K |
| Trigilio Jeffrey | CFO | 2023-04-12 | SELL | 318 | $10.22 | $3.2K |
| Michaelson Jennifer | Chief Development Officer | 2023-04-12 | SELL | 176 | $10.22 | $1.8K |
| AHMED NADIM | President and CEO | 2023-03-23 | SELL | 706 | $10.51 | $7.4K |
| Trigilio Jeffrey | CFO | 2023-03-20 | SELL | 399 | $11.32 | $4.5K |
| Jones Jeffrey Alan | Chief Medical Officer | 2023-03-20 | SELL | 390 | $11.32 | $4.4K |
| Michaelson Jennifer | Chief Development Officer | 2023-03-20 | SELL | 238 | $11.32 | $2.7K |
| SUMER JACQUELYN L | Chief Legal Officer | 2023-03-20 | SELL | 305 | $11.32 | $3.5K |
| Michaelson Jennifer | See Remarks | 2022-11-25 | SELL | 4,000 | $13.3 | $53.2K |
| Michaelson Jennifer | See Remarks | 2022-09-27 | SELL | 4,000 | $12.4 | $49.6K |
| Michaelson Jennifer | Chief Development Officer | 2022-08-08 | SELL | 1,385 | $15.01 | $20.8K |
| F2 Vision SCS | 10% Owner | 2022-08-04 | SELL | 49,910 | $14.26 | $711.7K |
| Michaelson Jennifer | Chief Development Officer | 2022-07-25 | SELL | 8,000 | $14.51 | $116.1K |
| Savill Corrine | Acting Chief Business Officer | 2022-07-19 | SELL | 20,000 | $15.18 | $303.6K |
| Savill Corrine | Acting Chief Business Officer | 2022-07-11 | SELL | 40,000 | $13.33 | $533.2K |
| F2 Bioscience I 2017 Ltd | 10% Owner | 2022-06-23 | SELL | 101,903 | $12.8 | $1304.4K |
| AHMED NADIM | President and CEO | 2022-06-06 | BUY | 8,090 | $12.4 | $100.3K |
| BIOTECHNOLOGY VALUE FUND L P | 2022-06-01 | BUY | 751,396 | $11 | $8265.4K | |
| F2 Vision SCS | 10% Owner | 2022-05-16 | SELL | 418,738 | $9.66 | $4045K |
| BIOTECHNOLOGY VALUE FUND L P | 2022-05-13 | BUY | 1,109,900 | $9.07 | $10066.8K | |
| BIOTECHNOLOGY VALUE FUND L P | 2022-04-01 | BUY | 276,000 | $10.75 | $2967K | |
| Michaelson Jennifer | See Remarks | 2021-10-18 | SELL | 4,000 | $21.42 | $85.7K |
| Trigilio Jeffrey | CFO | 2021-10-15 | SELL | 8,000 | $25 | $200K |
| Zawel Leigh | See Remarks | 2021-10-15 | SELL | 19,574 | $25 | $489.4K |
| Zawel Leigh | See Remarks | 2021-10-07 | SELL | 1,079 | $25 | $27K |
| Michaelson Jennifer | See Remarks | 2021-09-20 | SELL | 4,000 | $24.51 | $98K |
| Zawel Leigh | See Remarks | 2021-09-20 | SELL | 7,468 | $25.16 | $187.9K |
| Oncology Impact Fund (Cayman) | 10% Owner | 2021-09-16 | SELL | 3,124 | $29.06 | $90.8K |
| GADICKE ANSBERT | Director, 10% Owner | 2021-09-16 | SELL | 3,556 | $29.06 | $103.3K |
| Oncology Impact Fund (Cayman) | 10% Owner | 2021-09-15 | SELL | 13,531 | $29.17 | $394.7K |
| GADICKE ANSBERT | Director, 10% Owner | 2021-09-15 | SELL | 15,401 | $29.17 | $449.2K |
| Oncology Impact Fund (Cayman) | 10% Owner | 2021-09-13 | SELL | 23,253 | $29.23 | $679.7K |
| GADICKE ANSBERT | Director, 10% Owner | 2021-09-13 | SELL | 26,468 | $29.23 | $773.7K |
| Baeuerle Patrick | See Remarks | 2021-09-08 | SELL | 11,000 | $28.45 | $313K |
| Trigilio Jeffrey | CFO | 2021-09-08 | SELL | 15,000 | $28.48 | $427.2K |
| Oncology Impact Fund (Cayman) | 10% Owner | 2021-09-08 | SELL | 48,640 | $29.2 | $1420.3K |
| GADICKE ANSBERT | Director, 10% Owner | 2021-09-08 | SELL | 55,364 | $29.2 | $1616.6K |
| Zawel Leigh | See Remarks | 2021-09-07 | SELL | 28,118 | $28.95 | $814K |
| Oncology Impact Fund (Cayman) | 10% Owner | 2021-09-02 | SELL | 24,309 | $29.5 | $717.1K |
| GADICKE ANSBERT | Director, 10% Owner | 2021-09-02 | SELL | 27,669 | $29.5 | $816.2K |
| GADICKE ANSBERT | Director, 10% Owner | 2021-08-30 | SELL | 50,489 | $29.24 | $1476.3K |
| Oncology Impact Fund (Cayman) | 10% Owner | 2021-08-30 | SELL | 44,358 | $29.24 | $1297K |
| Oncology Impact Fund (Cayman) | 10% Owner | 2021-08-25 | SELL | 105,894 | $29.29 | $3101.6K |
| GADICKE ANSBERT | Director, 10% Owner | 2021-08-25 | SELL | 120,592 | $29.29 | $3532.1K |
| Zawel Leigh | See Remarks | 2021-08-23 | SELL | 28,118 | $29 | $815.4K |
| Zawel Leigh | See Remarks | 2021-08-23 | SELL | 28,118 | $29 | $815.4K |
| Michaelson Jennifer | See Remarks | 2021-08-18 | SELL | 4,000 | $27.66 | $110.6K |
| Michaelson Jennifer | See Remarks | 2021-08-18 | SELL | 4,000 | $27.66 | $110.6K |
| Oncology Impact Fund (Cayman) | 10% Owner | 2021-08-11 | SELL | 2,510 | $29.05 | $72.9K |
| GADICKE ANSBERT | Director, 10% Owner | 2021-08-11 | SELL | 2,857 | $29.05 | $83K |
| Zawel Leigh | See Remarks | 2021-08-10 | SELL | 28,118 | $26.77 | $752.7K |
| Baeuerle Patrick | See Remarks | 2021-08-10 | SELL | 11,000 | $27 | $297K |
| Zawel Leigh | See Remarks | 2021-08-10 | SELL | 28,118 | $26.77 | $752.7K |
| Oncology Impact Fund (Cayman) | 10% Owner | 2021-01-12 | BUY | 300,000 | $21 | $6300K |
| GADICKE ANSBERT | Director, 10% Owner | 2021-01-12 | BUY | 300,000 | $21 | $6300K |
| Jovan-Embiricos Morana | Director, 10% Owner | 2021-01-12 | BUY | 200,000 | $21 | $4200K |
| Hughes Owen | President and CEO | 2021-01-12 | BUY | 2,500 | $21 | $52.5K |
| Trigilio Jeffrey | CFO | 2021-01-12 | BUY | 2,250 | $21 | $47.3K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked